Evotec Competitors and Similar CompaniesClear all
Evotec's competitors and similar companies include Catalent.
 Catalent Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. | ||
Founding Date | Founding Date 1993 | Founding Date 2007 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Hamburg, DE HQ Lyon, FR Toulouse, FR Göttingen, DE Halle (Westfalen), DE Köln, DE Munich, DE see more | Locations Bridgewater, US HQ Buenos Aires, AR Bruxelles, BE Charleroi, BE Charleroi, BE Charleroi, BE Indaiatuba, BR see more |
Employees | Employees 4,766 | Employees 12,6955% increase |
Financial | ||
Revenue (est.) | Revenue (est.) €788.4m (FY, 2025) | Revenue (est.) $4.4b (FY, 2024) |
Cost of goods | Cost of goods €622.9m (FY, 2025) | Cost of goods $3.4b (FY, 2024) |
Gross profit | Gross profit €231.1m (FY, 2025) | Gross profit $953m (FY, 2024) |
Net income | Net income (€103.5m) (FY, 2025) | Net income ($1b) (FY, 2024) |
Operating ⚠ | ||
Customers | Customers 781 (FY, 2023) | Customers 1.2 k (FY, 2023) |
Products | Products 140 (FY, 2023) | Products 8 k (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 993.6m | Total funding raised $ 650m |
For sources of this data, please see the company profile
View Company Profiles
Catalent
HQ
Bridgewater, US
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
View company